A single-center, randomized, parallel design study to evaluate the efficacy of donepezil in improving visuospatial abilities in patients with mild cognitive impairment using eye-tracker: the COG-EYE study protocol for a phase II trial

BACKGROUND: Cholinesterase inhibitors (ChEIs) decrease long-term cognitive decline in patients with Alzheimer’s disease (AD); however, there is little evidence that ChEIs affect cognitive test scores in patients with mild cognitive impairment (MCI). Conventional endpoints, such as cognitive tests or...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Ko Woon, Wang, Qi, Koo, Se Hee, Shin, Byoung-Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513951/
https://www.ncbi.nlm.nih.gov/pubmed/36167553
http://dx.doi.org/10.1186/s13063-022-06781-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513951/
https://www.ncbi.nlm.nih.gov/pubmed/36167553
http://dx.doi.org/10.1186/s13063-022-06781-0

Ejemplares similares